Ahead Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Crowdfunding

  • Latest Deal Amount
  • $1.35M

  • Investors
  • 6

Ahead Therapeutics General Information

Description

Developer of a medical therapy technology designed to offer treatments for different auto-immune disorders. The company's technology is based on bio-mimicking efferocytosis causing apoptotic cells to be removed from the body by being recognized, recruited, and engulfed by immature dendritic cells, enabling doctors to provide treatment for different diseases such as type 1 diabetes, multiple sclerosis, and celiac disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Pier 07 Via Laietana 26, Entl.
  • Ciutat Vella
  • 08003 Barcelona
  • Spain
+34 935
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Corporate Office
  • Pier 07 Via Laietana 26, Entl.
  • Ciutat Vella
  • 08003 Barcelona
  • Spain
+34 935

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ahead Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Equity Crowdfunding 28-Feb-2024 $1.35M Completed Pre-Clinical Trials
9. Later Stage VC 15-Sep-2022 Completed Pre-Clinical Trials
8. Early Stage VC 14-Jun-2019 Completed Pre-Clinical Trials
7. Grant 31-May-2019 Completed Pre-Clinical Trials
6. Grant 06-May-2019 Completed Pre-Clinical Trials
5. Early Stage VC 13-Dec-2018 Completed Pre-Clinical Trials
4. Grant 21-Nov-2018 Completed Pre-Clinical Trials
3. Accelerator/Incubator 15-Oct-2018 Completed Startup
2. Early Stage VC 20-Dec-2017 $1.31M $1.31M Completed Startup
1. University Spin-Out 12-Dec-2017 Completed Startup
To view Ahead Therapeutics’s complete valuation and funding history, request access »

Ahead Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 166,500 $0.011212 $7.47 $7.47 1x $7.47 30.36%
To view Ahead Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ahead Therapeutics Patents

Ahead Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023385067-A1 Tolerogenic composition Pending 23-Nov-2022
EP-4622624-A1 Tolerogenic composition Pending 23-Nov-2022
US-20260000744-A1 Tolerogenic composition Pending 23-Nov-2022
WO-2024110516-A1 Tolerogenic composition Inactive 23-Nov-2022 A61K9/1271

Ahead Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ahead Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
EASME - EU Executive Agency for SMEs Corporation
INNVIERTE SICC Government
Institut Català de Finances Venture Capital Minority
Horizon 2020 Government
Richi Foundation Government Minority
You’re viewing 5 of 6 investors. Get the full list »

Ahead Therapeutics FAQs

  • When was Ahead Therapeutics founded?

    Ahead Therapeutics was founded in 2017.

  • Where is Ahead Therapeutics headquartered?

    Ahead Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of Ahead Therapeutics?

    Ahead Therapeutics has 20 total employees.

  • What industry is Ahead Therapeutics in?

    Ahead Therapeutics’s primary industry is Drug Discovery.

  • Is Ahead Therapeutics a private or public company?

    Ahead Therapeutics is a Private company.

  • What is Ahead Therapeutics’s current revenue?

    The current revenue for Ahead Therapeutics is .

  • How much funding has Ahead Therapeutics raised over time?

    Ahead Therapeutics has raised $5.83M.

  • Who are Ahead Therapeutics’s investors?

    EASME - EU Executive Agency for SMEs, INNVIERTE SICC, Institut Català de Finances, Horizon 2020, and Richi Foundation are 5 of 6 investors who have invested in Ahead Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process